Ipsen (United States)
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Ipsen (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
53%
Total
Publications
328
Total Open
Publications
175
Total
Citations
4K
Open Access
Percentage
53%
Total
Publications
328
Total Open
Publications
175
Total
Citations
4K
Breakdown
Publisher Open
25%
Both
26%
Other Platform Open
2%
Closed
47%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 24%
40
Hybrid 61%
103
No Guarantees 15%
25
Other Platform Open
Domain 87%
82
Institution 18%
17
Public 11%
10
Other Internet 10%
9
Preprint 1%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 82 |
Europe PMC | Domain | 29 |
Semantic Scholar | Public | 9 |
University of Edinburgh - Edinburgh Research Explorer | Institution | 2 |
University College London - UCL Discovery | Institution | 2 |
Universidad Autónoma de Madrid - Biblos-e Archivo | Institution | 2 |
Umeå University - DiVA at Umeå University | Institution | 2 |
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia | Other Internet | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - TYPE ART | Other Internet | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - Aix-Marseille Université | Institution | 2 |